1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Personalized Medicine and Epigenomics: Technologies and Global Markets

Personalized Medicine and Epigenomics: Technologies and Global Markets

  • March 2016
  • -
  • BCC Research
  • -
  • 227 pages

Summary

Table of Contents

This BCC Research report discusses the global epigenomic market in terms of growth, size and opportunities with regard to different therapies, technologies, as well as regionally. The report includes forecasted trends and revenue through 2020.

Use this report to:

Gain insight into the global market for epigenomics, including emerging opportunities in biomarkers, diagnostics and therapeutics.
Assess global epigenomic market by types, application areas, products, segments, and regions.
Identify market trends, issues and factors impacting the epigenomic market.

Highlights

The global epigenomic market reached nearly $4 billion in 2014 and $4.7 billion in 2015. The market should reach nearly $12.1 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 20.6% from 2015 to 2020.

North America dominated the global epigenomic market and reached $1.9 billion in 2015.

The market should reach $4.6 billion in 2020 at a CAGR of 19.9% from 2015 to 2020.

The Asia-Pacific epigenomic market reached nearly $1.0 billion in 2015, and should reach $2.8 billion by 2020 growing at a CAGR of 22.8% throughout the period.

INTRODUCTION

The report Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics discusses the global epigenomic market in terms of growth, size and opportunities with regard to different therapies, technologies, as well as regionally. The report includes forecasted trends and revenue through 2020. Major players, innovative products and technologies, trends and market dynamics, competitive intelligence and
regional trends are well-researched and analyzed.

STUDY GOALS AND OBJECTIVE

Define and discuss the global market for epigenomics, including emerging opportunities in biomarkers, diagnostics and therapeutics.
Analyze market structure by segments and subsegments.
Estimate market revenues by regions and products.
Identify market trends, issues and factors impacting the epigenomic market.
Explain opportunities with respect to regions and products.
Profile major players and analyze their core competencies and strategies.
Track alliances, joint ventures, mergers and acquisitions, new product developments, and research and development.

TITLE DESCRIPTION

The term epigenetics refers to the study of alterations in genes that are not facilitated by any change in DNA sequence. Epigenetics is essential for the development of mammals due to its benefits and threats. Epigenetic regulation is a key factor for the development of mammals and cellular differentiation. On the contrary, epigenetic dysregulation results in diseases, including cancer and various other genetic disorders.

The human genome consists of DNA, which is responsible for encoding genetic information. Epigenomes include histone and DNA modification layered on top of the genome. These are responsible for directing the genome to feed information to genes during particular events. The epigenetic condition of a cell is affected by both developmental and environmental factors, including nutrition, toxins, infection and drugs of abuse. Thus, epigenetics exhibits a close relationship between environment and genome.

The study of epigenetics has evolved over the years, leading to rapid changes on the technological front. Epigenetic study using DNA sequencing technology has enabled researchers to perform large-scale experiments as compared to micro-array approaches. Constant evolution in technology, including the adoption of more advanced sequencing techniques, is expected to assist researchers to perform experiments at supreme resolutions.

SCOPE OF THE REPORT

The report will analyze the market by types, products and applications. It will also focus on emerging technologies and therapies. Geographically, the market is divided into five regions: North America, Europe, the Asia-Pacific region and Latin America, and the Middle East and Asia (MEA).

Products are segmented by reagents, kits, instruments, enzymes and services.

Technologies are segmented by DNA methylation, histone methylation and acetylation, MicroRNA modification.
Applications are segmented areas by diagnosis, prognosis, therapy optimization in routine clinical treatment and drug discovery.

Therapy areas are segmented by cancer treatment, neurological disorders, CVD and others, which includes the research and development (R&D) stage.

Cancer treatment is further broken down into hematological cancers, solid tumors, gastric cancer, lung cancer and others.



Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.